www.cphi-preconnect.com

Choose from 6 Modules:

A. Generics & Super Generics in Emerging Markets NEW!

B. Drug Delivery Systems

presents

The latest information on industry trends, developments and emerging opportunities for the international pharma community

5th Annual

21 October Messe Frankfurt Germany

Pre-Connect Conference 2013

Alan Sheppard, Principal, Global Generics,Thought Leadership, IMS Health, UK

Nigel Langley, Head of Marketing Pharma Ingredients & Services, BASF (USA)

Harvinder Popli, Ex-Director of Corporate Development, Ranbaxy Laboratories (India), presently Managing Director, Zandria

50 leading industry experts, including:

C. Biosimilars & Biobetters

D. API Sourcing in Emerging Markets

E. Strategic Partnering

F. Pharma Packaging& Labelling NEW!

Where the Pharma community meets before visiting:

Year-on-year, CPhI Worldwide attracts over 29,500 attendees from over 130 countries and 2,200 exhibitors. Taking place the day before the main show opens, CPhI Worldwide Pre-Connect Conference is the best opportunity to participate in high-level discussions and network with the world’s leading pharmaceutical experts as they cover

cutting-edge content on technical updates and the latest trends.

Discover the key trends, drivers, challenges and opportunities in the generics and super generics industry in emerging markets

Obtain critical information about recent and upcoming advances in drug delivery systems

Learn from an in-depth analysis of the biosimilars and biobetters development pipeline of opportunities

Receive an update on working with the Chinese and Indian API manufacturing industries and discover alternative destinations for sourcing APIs

Get an in-depth understanding of pharmaceutical packaging and labelling and the most effective ways to ensure safety and security throughout the supply chain

With 6 modules on Generics and Super Generics in Emerging Markets, Biosimilars and Biobetters, Drug Delivery Systems, API Sourcing in Emerging Markets, Strategic Partnering and Pharmaceutical Packaging and Labelling, the CPhI Worldwide Pre-Connect Conference offers you an exclusive opportunity to join senior executives and influential speakers from across the Pharma industry and gain a head start on your networking in an informative and interactive environment.

Why not purchase a Full Conference Pass and gain access to the top 3 modules of your choice, exclusive networking and lunch?

180 Companies

50 Leading Industry Experts53 Countries26 Topic Areas6 Modules1 Exclusive Conference

Pre-Connect Conference 2013

Event-at-a-Glance Top 5 Reasons to Attend

New for 2013!

21 October, Messe Frankfurt, Germany

Join the Conversation! CPhI Global Pharma CPhIWW @CPhIWW #PreCon13

Timings CPhI Worldwide Pre-Connect Conference, Monday, 21 October

OR

OR

OR

10:00 – 12:00

13:00 – 15:00

15:00 – 16:00

16:00 – 18:00

12:00 – 13:00 Networking Lunch Break

Afternoon Networking Break

09:00 - 10:00 Conference Registration and Morning Coffee

Module AGenerics and Supergenerics in Emerging Markets

Module CBiosimilars and Biobetters

Module EStrategic Partnering

Module FPharma Packaging and Labelling

Module DAPI Sourcing In Emerging Markets

Module BDrug Delivery Systems

presents

Fast Facts!

The CPhI Worldwide Pre-Connect Conference has been designed so you can tailor your own agenda. Choose to attend a single conference module of your choice starting from €250 + Tax or the full conference giving you access to 3 modules*, lunch and networking opportunities.The full conference price starts from €700 + Tax.*Choose to attend 1 module from each of the tracks and times given above

The Conference will open your horizons and widen your knowledge and networking connections. It is a very valuable event – Upik Rosawati, Business Development Senior Manager, Kalbe Farma

Examining the Impact of Pricing and Reimbursement Controls in Emerging Markets Coping with increasing pricing pressures as a result of further reforms in India and Asia Building the right pricing strategy to accommodate the complexity of purchaser community in emerging markets The importance of government engagement to avoid price leakage Overcoming challenges with pricing and reimbursement controls Panel Discussion: Expanding into Emerging Markets Understanding regulatory environment, market characteristics and dynamics to find the right strategy and establish strong local presence to compete in unfamiliar markets Capitalising on acquisition opportunities to enter the emerging markets – acquiring for geographical expansion, technology and creating different business opportunities Examining challenges with IP protection, patent “evergreening”, increased requirements for pharmacovigilance on generic manufacturers and other challenges faced by market entrants Exploring market opportunities for super generics in China

Differentiating Your Business to Stay Competitive Pinpointing new growth markets – advantages of women’s health and psychiatric disorders segments Balancing risks and opportunities when getting into markets with high entry barriers What tools are available for SMEs to survive the price war and stay competitive?

Highlighting the Latest Innovations in Super Generics Capitalising on opportunities and increased scientific skills in emerging markets Technology transfer considerations when doing business in emerging markets Personalised medicines and reduced risk outlook in super generics therapy area for satisfying unmet medical needs Quality approach and value proposition in super generic business strategy model

11:50 Case study: Country Spotlight – Discovering Opportunities of Doing Business in India and China

Case Study: Excipient Innovations: Bioavailability Enhancement Utilizing Hot Melt Extrusion

Capitalising on Innovation for Effective Drug Formulation Improving drug delivery mechanisms - sustained release formulation How can enhanced collaboration among R&D and drug delivery improve formulation? What formulation techniques can help scientists tackle the problem of poor solubility?

Keynote Address: The Role of Nanomedicine in Drug delivery and Particle Engineering

Spray Congealing: An Emerging Technology in the Pharmaceutical Industry Spray congealing in taste masking and controlled release applications Comparing spray congealing against other traditional technologies Analysing critical process parameters and scale up considerations

Establishing Bioequivalence – In vitro and In vivo Testing and Practical Issues Associated with Various Approaches What is the current acceptance criteria for bioequivalence? Overview of most effective methodologies used to establish bioequivalence The potential effect of excipients on bioequivalence studies

Highlighting the Advances in Drug Delivery Devices Identifying the most promising segments of the drug delivery device market Examining the system approach for drug device combination products Implementing device strategy to prevent lost development time

Module A: Generics and Super Generics in Emerging Markets

Amplifying growth and capitalising on opportunities in emerging markets

Chaired by Alan Sheppard, Principal, Global Generics, Thought Leadership, IMS Health (UK)

Module B: Drug Delivery Systems

Embracing innovation through novel technologies

Chaired by Kurt Nielsen, Chief Technology Officer and Senior Vice President, R&D, Catalent (USA)

Sponsored by:

Choose between Module A or B, C or D and E or F as these modules run at the same time

TRACK 1 TRACK 2

10:00- 12:00

CPhI Worldwide Pre-Connect Conference Programme

International Peer-to-Peer Discussion: Navigating Regulatory Framework and Achieving Regulatory Approval and Compliance Understanding the current regulatory and approval standards for biosimilars in Europe and globally What improvements can be made to the current regulatory framework in Russia and CIS? Analysing Latin America’s regulatory landscape for biosimilars development

Analysing the Biosimilars and Biobetters Development Pipeline of Opportunities Which reference products are most targeted by biosimilar and biobetter developers? Indentifying the most active market players, countries and regions Which therapy areas are going to experience the most biosimilar entries? How many biosimilars and biobetters are expected to be on the market by 2015?

Case Study: Optimized Development of Biosimilars and Biobetters

Overcoming the Challenges in Biosimilar Development – Establishing and Demonstrating Biosimilarity Current regulatory aspects in biosimilarity in Europe, US and globally Monitoring reference product quality attributes Establishing biosimilarity during development – from early cell line development to full comparability exercise State of the art in protein analytics to demonstrate biosimilarity Scientific and quality considerations in demonstrating biosimilarity

Do Biosimilars Have the Potential to Compete with Generics? What different development approaches are companies adopting? What trends and patters are likely to emerge in the next few years? How is the market expected to evolve? How will the US and EU biosimilar markets compare to emerging markets by 2016?

Panel Discussion: An Overview of Chinese and Indian API Manufacturing Industries Analysing and comparing macro-economic environment in China and India The impact of rapidly increasing salaries in India and China as compared to regulated markets High turnover of personnel and its affect on labour costs The expense of environmental compliance in China Assessing the financial impact of sourcing and hidden costs of doing business in Asia

Panel Discussion: Overcoming Regulatory Hurdles and Ensuring Market Access How do emerging markets respond to FDA’s maintenance charges for updating DMF status? How do suppliers react to the tightened controls over Falsified Medicines? Ensuring the quality of starting materials 1995 patent law and its implication on Indian API companies

Sourcing APIs, Generic Formulations & OTC Drugs from Indian Pharmaceutical Manufacturers Examining the opportunities and challenges of sourcing APIs, generic formulations and OTC drugs from India Complying with GMP manufacturing regulations Analysing the factors behind the deficiencies with global GMP standards and suggesting effective solutions Learning to navigate the Indian drug manufacturer supply chain channels Overview of the new US FDA initiatives to safeguard American pharmaceutical supply chain

Looking at Alternative Sourcing Destinations to India and China What are the most promising alternative sourcing destinations? South Korea, Taiwan Brazil Russia, CIS and Eastern Europe What factors are driving manufacturers to search for strategic advantages in other markets?

Panel Discussion: API Sourcing: The Supplier’s Perspective An overview of business and political pressures on API suppliers. Ways to relieve these pressures through API sourcing How can API suppliers ensure that the quest for cost improvements doesn’t compromise quality and security of supply? Establishing long term relationship and commitment between a supplier and sourcing company Overcoming the risk of sourcing from a less established buyer

Module C: Biosimilars and Biobetters

Embracing the next generation of biopharmaceuticals through effective development and commercialisation

13:00 – 15:00

Chaired by Michael E. Jenkins, PhD, General Manager, Catalent Biologics (USA)

Module D: API Sourcing in Emerging Markets

Evaluating the current environment in India & China and the potential of second wave emerging markets as a new sourcing destinations

Chaired by Thomas Speace, President and CEO, Neuland Laboratories (USA)

Sponsored by:Sponsored by:

Turn to page 6 to see the list of Pre-Connect Conference Speakers!

CPhI Worldwide Pre-Connect Conference Programme

13:00- 15:00

Pre Connect Conference is the only choice for the Monday before CPhI

Richard Dicicco, President, Harvest Moon Pharmaceuticals

Panel Discussion: Key Drivers, New Trends and Considerations for Effective Strategic Partnerships

What are the key factors driving Donors to outsource in the current business environment? Have small and mid-tier CROs been left behind? What strategy can they adopt to establish

them selves on the market as a potential partner? What recent improvements and methods have been implemented in streamlining the

process of finding the right strategic partner? Cost, time and other crucial factors to be considered when seeking and developing a

strategic partnership Entering the Asian market place to increase sales and distribution. What benefits can Asia

provide?

Risk Assessment During Technical Transfer Ways to ensure a quick, efficient transfer of process and knowledge that meets all necessary

quality and regulatory requirements Overview of the most common approaches to technical transfer – choosing the right one Risk and cost sharing in drug development Showcasing an evolution of risk assessment framework and its successful implementation in

the real-world technical transfer

Case Study: Moving Beyond Supplier Relationship Management - Better Leveraging Unique Capabilities to Create Greater Value with Pharma

Analysing the need for entire value chain to address the imperative of “doing more with less” Understanding the key challenges and opportunities in the healthcare sector and Pharma

industry Identifying the unique capabilities in supplier community which best address unmet needs Understanding supplier-buyer relationships in the framework of the Trading Relationship model

Case Study: Realising New Value and Reducing Risks Through Strategic Supplier Relationship Management - Programme by Means of Collaboration, Early Launch and Innovation

Procurement’s Role in Innovation Process The innovation landscape – results from Pharma Focus sessions The innovation process – a direction towards best practice Organizational maturity: how does it impact trading relationships and supports the innovation

acquisition process?

Module E: Strategic Partnering

Finding alignment between opportunities and obstacles in strategic partnering to maximise R&D productivity

16:00- 18:00

Chaired by Jo Pisani, Partner, Strategy team, PwC (UK) Chaired by Michael Nieuwesteeg, Managing Director, NVC Packaging Centre (Netherlands)

Sponsored by:

Module F: Pharmaceutical Packaging and Labelling

Achieving efficiency, safety, security and patient compliance throughinnovative management techniques

Powered by:

Keynote Address: Applying the New ISO Standards on Packaging and Environment in the Pharmaceutical Market: The Devil is in the Detail

Supply Chain Security

Visibility for patient safety and supply chain efficiency Ensuring visibility throughout the supply chain and analysing various traceability models Implementing global standards and solutions to improve the efficiency and visibility of HC

supply chain Achieving regulatory compliance for the globally harmonised approach to labelling Sustaining the momentum of implementation as it’s rapidly gathering pace

Panel Discussion: Mas- Serialisation and Tamper Proof Evidence Reviewing the most effective strategies for tamper prevention Pharmaceutical serialisation and the EU’s Falsified Medicines Directive – latest updates and

expectations for the year ahead Identifying the ways to minimise the costs of features that prevent falsification

A Global Approach to Labelling – Is this Achievable?

What are the challenges associated with different labelling requirements within separate countries?

Best approaches to adopt when ensuring the labelling process for global supply Standardising the labelling to serve a multilingual market Minimizing the costs associated frequent commercial reprinting and addressing the problems

associated with multiple label amendments

Case study: Using New Technologies as a Way to Reduce Costs What are the latest advances of new technology with packaging and what business benefits

can be realised across the supply chain? Determining the impact new machinery would have on the quality of the product and

overcoming problems that could arise from using it Considering and justifying the costs associated with the implementation of new technologies Ensuring the smooth and efficient running of production during the implementation stage

CPhI Worldwide Pre-Connect Conference Programme continued

Register Now! www.cphi-preconnect.com +44(0)844 557 2788

Speakers:Roger Bakale, Senior Director, Chemical Process R&D, Teva (USA)Ken Phelps, CEO/President, Camargo Pharmaceutical Services (USA)Nicola Travierso, General Manager, NTC SRL (Italy)Fereshteh Barei, Health Economist and Strategy Ad5visor, LEGOS Laboratory for Health Economics and Management, Dauphine University Paris (France)Gurpreet Sandhu, Managing Director, Reva Pharma (India)Alan Sheppard, Principal, Global Generics, Thought Leadership, IMS Health (UK)

Module A: Generics and Super Generics in Emerging MarketsAmplifying growth and capitalising on opportunities in emerging markets

Speakers:Dr. Nigel Langley, Head of Marketing Pharma Ingredients & Services, BASF (USA) Okke Franssen, Director of Pharmaceutical Development, Nanomi (Netherlands)Dr Claus-Michael Lehr, Co-founder and Head of the Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (Germany)Stefan Leiner, Chemical-Pharmaceutical Expert, Boehringer Ingelheim Pharma (Germany)Harvinder Popli, Director of Corporate Development, Ranbaxy Laboratories (India)Kurt Nielsen, Chief Technology Officer and Senior Vice President, R&D, Catalent (USA)Conrad Winters, Director, Drug Product Development, R&D, Hovione (Portugal)

Module B: Drug Delivery Systems Embracing innovation through novel technologies

Speakers:Roman Ivanov, Vice President, R&D, BIOCAD (Russia)Josélia Manfio, Executive Director, Biocinese (Brazil)Nick Hyde, Principal, Greenville Management (UK)Magdalena Leszczyniecka, President and CEO, STC Biologics (USA)Martin Blüggel, Chief Business Officer, Protagen Protein Services (Germany)Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals (USA)Michael E. Jenkins, PhD., General Manager, Catalent Biologics (USA)Rob Gustines, Technical Director, Catalent Biologics (USA)

Module C:Biosimilars and BiobettersEmbracing the next generation of biopharmaceuticals through effective development and commercialisation

Speakers:Ian Lennon, Senior Vice President, Global Business Development, Chiral Quest (UK)Gurpreet Sandhu, Managing Director, Reva Pharma (India)Jamie Davies, Head of Pharmaceuticals, Medical Devices and Healthcare, Business Monitor International (UK) Thomas Speace, President and CEO, Neuland Laboratories (USA)Theodore Iliopoulos, Chief Scientific Officer, Euticals (Italy)Kate Kuhrt, Senior Director, Generics Intelligence and Content Strategy, Thomson Reuters (USA)Wei-Chyun Wong, General Manager, SCI Pharmtech (Taiwan)Michael Humora, Principal Scientist, Process Chemistry, Biogen Idec (USA)Martyn Peck, VP, Business Development, Laurus Labs Private Ltd (India)Howard Kim, Director, Business Development, Yonsung Fine Chemicals (Republic of South Korea) Mohal Sarabhai, CEO, Asence Inc. (USA)Ronald Lamounier Rubinstein, Managing Director, ITF Chemical Ltda (Brazil)

Module D: API Sourcing in Emerging Markets Evaluating the current environment in India and China and the potential of second wave emerging markets as a new sourcing destinations

Speakers:Martin Folger, Head of Pharmaceutical Development, Boehringer Ingelheim Vetmedica (Germany)Ulrich Ruemenapp, Head Biotech Projects, Bayer Pharma (Germany)Hairong (Angela) Zhou, Scientific Manager, Genentech (USA)Jo Pisani, Partner, Strategy team, PwC (UK)Mairead Fogarty, Senior Director of Process Development and Scale-up, Alkermes (Ireland)Giles Breault, Head of Productivity Service Solutions, Novartis Pharma (Switzerland)Cristian Lienas, Global Sourcing Category Manager, Almirall (Spain)Transactions, Sanofi Pasteur (USA)

Module E: Strategic PartneringFinding alignment between opportunities and obstacles in strategic partnering to maximise R&D productivity

Speakers:Ulrike Kreysa, Vice-President Healthcare, GS1 Global (Belgium)Michael Nieuwesteeg, Managing Director, NVC Packaging Centre (Netherlands)Dirk Hendrik Kneusels, Commercial Director, Laetus GmbH (Germany)Dr. Marietta Ulrich-Horn, CEO, Securikett (Germany)Vince Postill, SVP of Business Development, PRISYM ID (UK) Heico Munzinger, Regional Sales Director, Hapa (Germany)

Module F:Pharmaceutical Packaging and LabellingAchieving efficiency, safety, security and patient compliance through innovative management techniques

21 October, Messe Frankfurt, Germany

Pre-Connect Conference Speakers

Register Now! www.cphi-preconnect.com +44(0)844 557 2788

CPhI Worldwide Pre-Connect Conference can offer you exceptional opportunities to network, raise your profile in the local business community and gain valuable access to influential opinion-leaders, decision-makers and entrepreneurs at the heart of pharmaceutical and biotech industries.

Align with the CPhI Worldwide Pre-Connect Conference, the ideal opportunity for:

Thought LeadershipPre-Connect provides an ideal opportunity for innovative providers to shape industry thinking and position their business as a leading light in pharmaceutical ingredients and related topics.

Lead DevelopmentDesigned for executives spanning Business and Product Development, Formulation Science and Technology, Global Sourcing and Partnerships, Clinical Research and Regulatory Affairs, the event provides partners with first-rate opportunities to meet with active decision makers and key influencers in the pharmaceutical community. The chance to meet and provide a clear value proposition to those that matter, shortening and building clear pipelines for future business development.

BrandingWith more than 250 attendees this event provides the chance to position your brand to both the European and international community. The perfect way to establish and strengthen brand credibility by making sure your solutions is front of mind for all attendees.

Becoming an event sponsor will enable you to demonstrate your expertise and showcase your innovative products, maintain visibility with existing customers and secure new contacts, referrals and leads.

Benefits available exclusively to sponsors include: Pre-arranged business meetings Scope to influence the agenda through master classes, session partnership, workshops and pre-conference seminars Focused networking opportunities via hosting lunches or evening cocktail receptions Targeted branding exposure through our comprehensive marketing campaigns and enhanced on-the-day visibility

Request a consultationSponsorship packages can be tailored to meet your specific business development needs. To request a consultation on available opportunities with our global business development team call +44(0)207 368 9500 or email Martin Wilson at martin.wilson@ubm.com.

We have opportunities for Media Partners such as major associations and publishers to co-promote their services alongside the Pre-Connect Conference. If you would like to find out more about how to get involved as an association or a publisher media partner please contact Stephanie McMillan on +44(0)207 955 3921 or email stephanie.mcmillan@ubm.com.

Following the Pre-Connect Conference, join us for CPhI Worldwide 2013 (22-24 October), the world’s leading pharmaceutical networking event with over 29,000 attendees from 133 countries and 2,200 exhibitors. Meet face-to-face with international pharmaceutical companies, stay informed about the latest industry trends and remain one step ahead of a constantly changing pharmaceutical market.

CPhI Worldwide provides 3 days to drive business the rest of the year: Meet the entire pharma industry in one location, find companies across key sectors, meet companies from around the world and keep up on the latest industry developments. Plus, free access to all co-located events including ICSE, P-MEC Europe and InnoPack. Register online today at www.cphi.com for your FREE expo pass, including the option to choose a VIP conference package offering exclusive benefits for visitors, including access to the VIP Business Lounge and the Pharma Awards Party.

CPhI Worldwide Pre-Connect Conference

SPONSORSHIP OPPORTUNITIES PARTNERING OPPORTUNITIES

10:00 – 18:00, 21 October, Messe Frankfurt, Germany

Special offer for CPhI Worldwide exhibitors - Receive a 20% discount off the standard price to attend Pre-Connect! Quote code: EXB20

Hosted alongside CPhI Worldwide exhibition, this year’s exclusive free content gives you a unique opportunity to learn more about already well established and up-and-coming pharmaceutical sectors. Run across three exhibition days our informative In-Focus Sessions will provide you with a chance to assess the opportunities in lucrative markets of Animal Health, Natural Extracts and Biopharmaceuticals.

Hear from IMS Health, KLIFOVET, Trifermed, Frost & Sullivan, Prati-Donaduzzi, RNI Consulting and many more. Remember to stop by the show floor and receive essential insight into these promising markets absolutely free of charge!

22 October 2013

23 October 2013

24 October 2013

In-Focus Session: Animal Health

In-Focus Session: Natural Extracts as a Source of Preventative Healthcare

In-Focus Session: Biopharmaceuticals

10:00 - 11:30

10:00 - 11:30

09:40 - 10:40

15:00 - 16:30

14:30 - 16:00

15:00 - 16:30

Understanding of the regulations and approval process for veterinary drugs in different continents

Borderline Products: Opportunities to Market Products as Non-veterinary Medicinal Products in Animal Health in Europe

The future of manufacturing technologies: promoting innovation in complex biopharmaceutical manufacturing The Challenge of Access to Biopharmaceuticals as Costs Drive Unaffordable Market Growth

Market Opportunities for Ingredient Manufacturers Regulatory Landscape for Natural Extracts

Partnerships in Animal Health: An Essential Pathway for Success Case Study: Looking for Establishing Effective Partnerships Models

Global Biopharmaceutical Contract Manufacturing Market – Quantitative and Qualitative Analysis Outsourcing as viable R&D and manufacturing strategies: adapting business models to maintain the market position

Promoting Quality Assurance and Technical Standards Innovation and Technological Advances in Manufacturing of Natural Extracts

Messe FrankfurtLudwig-Erhard-Anlage 1, 60327 Frankfurt, GermanyT: +49 69 75 75-0F: +49 69 75 75-64 33W: www.messefrankfurt.com

1. The Conference is organised by UBMi BV (the “Organiser”), whose office is at de Entree, Toren A, 1101 BH, Amsterdam, The Netherlands. 2. You apply for a ticket to the Conference by completing this Order Form. The Organiser may at its absolute discretion accept or refuse your application. A binding contract will be formed only when the Organiser provides you with its written acceptance of your application. 3. By purchasing a ticket to the Conference, you agree to: comply with any joining instructions in respect of the Conference; and comply with the health and safety provisions and other rules put in place by the Conference venue.

12. All bookings made within 30 days of the conference must be paid by credit card only. It may be necessary due to unforeseen circumstances to alter the content, timing, speakers or venue. VAT: Under EU Customs and Excise regulations delegates are required to pay VAT on any conference taking place within the EU. Delegates may be entitled to reclaim this cost. In conjunction with Tax Back International VAT Reclaim, the world’s leading VAT recovery organisation, you can make a significant reduction on your attendance costs. For more information please contact Tax Back International on Tel: +353 1 878 3361.

4. The Organiser reserves the right, due to unforeseen circumstances, to alter the: content; location; timetable; speakers; venue; and/or other technical or administrative details in respect of the Conference. The Organiser will endeavour to provide you with notice of any such alterations. 5. You may transfer your ticket to another individual within the same company or group of companies PROVIDED that the recipient of the ticket would have been eligible to purchase the ticket at the price that you paid for it. 6. You may cancel your ticket to attend the Conference if you provide written notice to the Organiser which we receive at least 30 days prior to the commencement of the Conference and the Organiser provides written acknowledgement of such notice. If you provide notice in this way, you will be refunded if you have already paid for your ticket.

provides written acknowledgement of such notice. If you provide notice in this way, you will be refunded if you have already paid for your ticket. 7. If you fail to provide us with written notice which is acknowledged by the Organiser in accordance with section 6, you will be required to pay the full cost of your ticket. If you have already paid for your ticket, no refund will be given. 8. The Organiser’s liability for any losses you may suffer as a result of us breaching these terms and conditions or for any breach of any statutory duty or negligence or otherwise is strictly limited to the total purchase price of the Conference ticket or (if liability occurs in respect of more than one ticket) those relevant Conference tickets. 9. To the maximum extent permitted by law, neither the Organiser nor any of its directors, employees or other representatives will be liable for any

of the following losses or damage (howsoever arising and whether such losses were foreseeable or not): loss of profit; loss of revenue; loss of business or opportunity; loss of reputation or goodwill; and/or any indirect, consequential or special loss; whether arising in connection with the Conference or the provision of our services to you. 10. Nothing in these terms and conditions shall exclude the Organiser’s liability for (i) death or personal injury as a result of its negligence; (ii) fraud or fraudulent misrepresentation; or (iii) any liability that cannot be limited or excluded by law. 11. These terms and conditions and any dispute or claim arising out of or in connection with them or their subject matter, shall be subject to English law and the exclusive jurisdiction of the English courts.

CONFERENCE RATES*

STANdARd RATE ON-SiTE RATE

Web: www.cphi-preconnect.com Tel: 0844 557 2788 (UK) or +44 (0)844 557 2788 (Int’l) Email: conferencedepartment@ges.com

HOW TO REGISTER

Group Booking Discounts Available

CONFERENCE MODULES

10:00 – 12:00 Module A: Generics & Super oR Module B: Drug Delivery Systems Generics in Emerging Markets 13:00 – 15:00 Module C: Biosimilars & Biobetters oR Module d: API Sourcing in Emerging Markets 16:00 – 18:00 Module E: Strategic Partnering oR Module F: Pharmaceutical Packaging & Labelling

When booking your place online or over the phone, you can choose to attend a single module only OR the full conference. If you would like to attend the full conference you will be able to select 3 modules, one from each of the times given below.

Please note the full conference pass also gives you access to exclusive networking, lunch and a sponsored dinner at the end of the day. Registering for the single module option allows you entry into that conference module only.

CPhI Worldwide Pre-Connect Conference

Group booking rates are available - please contact us on +44 (0)207 921 8039 to find out more.

VENUE:TRAVEL:

Events in Focus have once again been appointed as the official hotel and travel agency for CPhl in 2013. Due to the high demand for hotel accommodation for this event we are advising delegates to make their booking early.

For more information, please contact:Mr. Randy WrightT: +44 (0) 207 902 7761F: +44 (0) 207 633 9427E: rw@eventsinfocus.net

Single conference module

Full conference

(attend 3 modules) Includes access to refreshments, lunch, networking and dinner

Book by 18 October 2013

Take advantage of Free Extra Content!

€1100SAVE €200

€1300

€400SAVE €100

€500

* all pricing includes VAT